Update shared on 07 Dec 2025
Analysts raised their price target on Cadre Holdings to $44 from $35, citing increased visibility and confidence in the company’s expanding nuclear safety and energy segments as key drivers of the upward revision.
Analyst Commentary
Bullish analysts framed the higher price targets as a function of both improved visibility into Cadre Holdings' nuclear safety operations and sustained execution in its legacy businesses, arguing that the company now has a clearer multi year growth narrative that justifies a premium valuation.
The recent investor day was cited as a key inflection point, with management detailing the structure and strategy of the newly organized Nuclear Group, which had previously been perceived as opaque by many generalist investors.
Bullish Takeaways
- Bullish analysts view the expanded disclosure around the nuclear safety platform as reducing the perceived risk discount and supporting higher valuation multiples.
- The Nuclear Group is seen as a long duration growth driver, with exposure to cleanup projects and energy production tied to secular demand, including AI driven power needs.
- Core operations are described as performing well, giving analysts more confidence in Cadre Holdings' ability to fund and execute on nuclear growth initiatives without compromising profitability.
- The combination of visible nuclear growth and steady core performance is seen as enhancing earnings power over time, underpinning the upward revisions to price targets.
Bearish Takeaways
- Bearish analysts highlight that the nuclear segment, while promising, still carries execution risk as the company scales new projects and integrates the reorganized Nuclear Group.
- Some remain cautious that investor expectations for nuclear related growth could get ahead of actual contract timing and regulatory milestones, creating potential volatility in the shares.
- There is concern that increased capital and management focus on nuclear opportunities could pressure near term margins or divert resources from the proven core business.
- Valuation sensitivity remains a focus, with more cautious views stressing that a premium multiple assumes continued flawless execution across both legacy and nuclear segments.
What's in the News
- Hosted an Analyst and Investor Day outlining Cadre Holdings' track record of value creation, strategic execution, operating model, and five-year growth vision, and emphasizing long-term industry tailwinds supporting its nuclear safety and core businesses (Key Developments)
Valuation Changes
- The fair value estimate remains unchanged at approximately $48.50 per share, indicating no revision to the long term intrinsic value assessment.
- The discount rate has risen slightly from about 7.89 percent to 7.91 percent, reflecting a marginal increase in the implied cost of capital.
- Revenue growth is effectively unchanged at roughly 9.21 percent, signaling stable expectations for top line expansion.
- The net profit margin is effectively unchanged at about 8.95 percent, suggesting no material shift in long term profitability assumptions.
- The future P/E has risen slightly from roughly 33.77x to 33.79x, indicating a modestly higher valuation multiple applied to forward earnings.
Have other thoughts on Cadre Holdings?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
